AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | - EUR | -149.29% |
| 2022 | 507.75 Thousand EUR | -29.6% |
| 2021 | 721.19 Thousand EUR | 385.63% |
| 2020 | 148.5 Thousand EUR | 209.28% |
| 2019 | 48.01 Thousand EUR | 146.04% |
| 2018 | -104.3 Thousand EUR | -143.51% |
| 2017 | 239.69 Thousand EUR | 117.47% |
| 2016 | 110.22 Thousand EUR | 114.89% |
| 2015 | -740.36 Thousand EUR | -167.68% |
| 2014 | 1.09 Million EUR | 430.76% |
| 2013 | -330.75 Thousand EUR | -313.48% |
| 2012 | -79.99 Thousand EUR | 22.35% |
| 2011 | -103.01 Thousand EUR | 37.39% |
| 2010 | -164.52 Thousand EUR | -158.41% |
| 2009 | -63.66 Thousand EUR | -256.12% |
| 2008 | 40.78 Thousand EUR | -90.57% |
| 2007 | 432.4 Thousand EUR | 86.77% |
| 2006 | 231.51 Thousand EUR | -30.56% |
| 2005 | 333.42 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 63.95 Thousand EUR | 136.1% |
| 2024 Q2 | -167.18 Thousand EUR | -361.4% |
| 2023 Q4 | -177.15 Thousand EUR | -168.38% |
| 2023 Q1 | -160.99 Thousand EUR | -163.73% |
| 2023 FY | -250.29 Thousand EUR | -149.29% |
| 2023 Q3 | 259.07 Thousand EUR | 384.91% |
| 2023 Q2 | -90.93 Thousand EUR | 43.52% |
| 2022 Q1 | 374.96 Thousand EUR | 43.3% |
| 2022 Q3 | 22.54 Thousand EUR | 125.38% |
| 2022 Q2 | -88.81 Thousand EUR | -123.69% |
| 2022 Q4 | 252.62 Thousand EUR | 1020.74% |
| 2022 FY | 507.75 Thousand EUR | -29.6% |
| 2021 Q3 | 255.36 Thousand EUR | 159.16% |
| 2021 Q2 | 98.53 Thousand EUR | -43.32% |
| 2021 Q4 | 261.65 Thousand EUR | 2.46% |
| 2021 FY | 721.19 Thousand EUR | 385.63% |
| 2021 Q1 | 173.84 Thousand EUR | 241.06% |
| 2020 FY | 148.5 Thousand EUR | 209.28% |
| 2020 Q1 | 46.98 Thousand EUR | -3.68% |
| 2020 Q2 | 54.66 Thousand EUR | 16.34% |
| 2020 Q3 | 170.1 Thousand EUR | 211.19% |
| 2020 Q4 | -123.24 Thousand EUR | -172.45% |
| 2019 Q4 | 48.78 Thousand EUR | -72.13% |
| 2019 Q1 | -18.47 Thousand EUR | -145.77% |
| 2019 Q3 | 175.04 Thousand EUR | 211.25% |
| 2019 FY | 48.01 Thousand EUR | 146.04% |
| 2019 Q2 | -157.34 Thousand EUR | -751.82% |
| 2018 Q1 | 34.53 Thousand EUR | -77.52% |
| 2018 FY | -104.3 Thousand EUR | -143.51% |
| 2018 Q4 | 40.36 Thousand EUR | 90.61% |
| 2018 Q3 | 21.17 Thousand EUR | 110.57% |
| 2018 Q2 | -200.36 Thousand EUR | -680.22% |
| 2017 Q2 | -231.09 Thousand EUR | -260.33% |
| 2017 Q1 | 144.14 Thousand EUR | 100.87% |
| 2017 FY | 239.69 Thousand EUR | 117.47% |
| 2017 Q3 | 173.03 Thousand EUR | 174.87% |
| 2017 Q4 | 153.62 Thousand EUR | -11.22% |
| 2016 Q1 | 30.14 Thousand EUR | 106.34% |
| 2016 Q4 | 71.75 Thousand EUR | -20.93% |
| 2016 FY | 110.22 Thousand EUR | 114.89% |
| 2016 Q3 | 90.75 Thousand EUR | 210.08% |
| 2016 Q2 | -82.44 Thousand EUR | -373.45% |
| 2015 Q4 | -475.2 Thousand EUR | -313.25% |
| 2015 Q3 | -114.99 Thousand EUR | -135.45% |
| 2015 Q1 | -101.33 Thousand EUR | -111.19% |
| 2015 Q2 | -48.83 Thousand EUR | 51.8% |
| 2015 FY | -740.36 Thousand EUR | -167.68% |
| 2014 Q4 | 905.87 Thousand EUR | 477.48% |
| 2014 Q1 | 74.42 Thousand EUR | -23.99% |
| 2014 Q3 | 156.86 Thousand EUR | 463.35% |
| 2014 FY | 1.09 Million EUR | 430.76% |
| 2014 Q2 | -43.17 Thousand EUR | -158.01% |
| 2013 Q4 | 97.91 Thousand EUR | 294.81% |
| 2013 FY | -330.75 Thousand EUR | -313.48% |
| 2013 Q3 | 24.8 Thousand EUR | 110.24% |
| 2013 Q1 | -211.38 Thousand EUR | -179.64% |
| 2013 Q2 | -242.08 Thousand EUR | -14.52% |
| 2012 Q4 | 265.4 Thousand EUR | 292.7% |
| 2012 FY | -79.99 Thousand EUR | 22.35% |
| 2012 Q1 | -28.65 Thousand EUR | -130.16% |
| 2012 Q2 | -179.01 Thousand EUR | -524.64% |
| 2012 Q3 | -137.73 Thousand EUR | 23.06% |
| 2011 Q2 | -171.84 Thousand EUR | -1098.57% |
| 2011 FY | -103.01 Thousand EUR | 37.39% |
| 2011 Q1 | 17.2 Thousand EUR | 154.35% |
| 2011 Q4 | 95.03 Thousand EUR | 318.93% |
| 2011 Q3 | -43.4 Thousand EUR | 74.74% |
| 2010 Q4 | -31.66 Thousand EUR | -111.08% |
| 2010 Q1 | -131.42 Thousand EUR | -142.24% |
| 2010 FY | -164.52 Thousand EUR | -158.41% |
| 2010 Q2 | -287.25 Thousand EUR | -118.57% |
| 2010 Q3 | 285.82 Thousand EUR | 199.5% |
| 2009 Q2 | 5299.59 EUR | -83.14% |
| 2009 Q3 | -46.15 Thousand EUR | -970.93% |
| 2009 FY | -63.66 Thousand EUR | -256.12% |
| 2009 Q4 | -54.25 Thousand EUR | -17.54% |
| 2009 Q1 | 31.44 Thousand EUR | 0.0% |
| 2008 FY | 40.78 Thousand EUR | -90.57% |
| 2007 FY | 432.4 Thousand EUR | 86.77% |
| 2006 FY | 231.51 Thousand EUR | -30.56% |
| 2005 FY | 333.42 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|